drugset / Trial / NCT05650645

The Efficacy of Incobotulinum Toxin A Injections for Treatment of Tinnitus: a Randomized Controlled Trial

NCT05650645 ↗

Phase 2 Completed 41 enrolled University of Minnesota
RandomizedParallel-groupTriple-blindTreatment

Summary

Tinnitus is a persistent non-physiologic, non-psychiatric, ringing in the ear that affects up to 20% of the general US population. The purpose of this study is to assess the patient reported effectiveness of Xeomin (incobotulinumtoxinA) injections into the auricular muscles for relief of tinnitus with use of the Tinnitus Handicap Inventory questionnaire.

Timeline

Start
2023-01-01
Primary completion
2025-12-29
Completion
2025-12-29

Drugs

EvaluationDrugModalityDoseRoute
Subject Botulinum toxin type A Protein / enzyme biologic 50 iu Intramuscular

Indications